Spark Therapeutics : Swiss drugmaker Roche again extends $4.3 billion Spark offer until December 16
12/09/2019 | 01:19am EST
Swiss drugmaker Roche again extended its offer for shares of gene therapy specialist Spark Therapeutics to Dec. 16 as a regulatory review of the $4.3 billion (3.35 billion pounds) transaction drags on.
All terms and conditions of Roche's offer remain unchanged, it said in a statement on Monday.
(Reporting by John Miller; editing by Thomas Seythal)